Stefansson IM - Search Results

1

Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.

Raeder MB, Birkeland E, Trovik J, Krakstad C, Shehata S, Schumacher S, Zack TI, Krohn A, Werner HM, Moody SE, Wik E, Stefansson IM, Holst F, Oyan AM, Tamayo P, Mesirov JP, Kalland KH, Akslen LA, Simon R, Beroukhim R, Salvesen HB. Raeder MB, et al. Among authors: stefansson im. PLoS One. 2013;8(2):e54873. doi: 10.1371/journal.pone.0054873. Epub 2013 Feb 5. PLoS One. 2013. PMID: 23393560 Free PMC article.

2

Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.

Stefansson I, Akslen LA, MacDonald N, Ryan A, Das S, Jacobs IJ, Salvesen HB. Stefansson I, et al. Clin Cancer Res. 2002 Jan;8(1):138-43. Clin Cancer Res. 2002. PMID: 11801550

3

Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma.

Salvesen HB, Stefansson I, Kalvenes MB, Das S, Akslen LA. Salvesen HB, et al. Cancer. 2002 Apr 15;94(8):2185-91. doi: 10.1002/cncr.10434. Cancer. 2002. PMID: 12001116 Free article.

4

Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.

Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA. Salvesen HB, et al. APMIS. 2003 Nov;111(11):1011-8. doi: 10.1111/j.1600-0463.2003.apm1111103.x. APMIS. 2003. PMID: 14629267

5

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

Stefansson IM, Salvesen HB, Akslen LA. Stefansson IM, et al. J Clin Oncol. 2004 Apr 1;22(7):1242-52. doi: 10.1200/JCO.2004.09.034. J Clin Oncol. 2004. PMID: 15051772

6

Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.

Stefansson IM, Salvesen HB, Immervoll H, Akslen LA. Stefansson IM, et al. Histopathology. 2004 May;44(5):472-9. doi: 10.1111/j.1365-2559.2004.01882.x. Histopathology. 2004. PMID: 15139995

7

Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series.

Macdonald ND, Salvesen HB, Ryan A, Malatos S, Stefansson I, Iversen OE, Akslen LA, Das S, Jacobs IJ. Macdonald ND, et al. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):957-65. doi: 10.1111/j.1048-891X.2004.014535.x. Int J Gynecol Cancer. 2004. PMID: 15361209

8

Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.

Salvesen HB, Stefansson I, Kretzschmar EI, Gruber P, MacDonald ND, Ryan A, Jacobs IJ, Akslen LA, Das S. Salvesen HB, et al. Int J Oncol. 2004 Dec;25(6):1615-23. Int J Oncol. 2004. PMID: 15547698

9

Low frequency of BRAF and CDKN2A mutations in endometrial cancer.

Salvesen HB, Kumar R, Stefansson I, Angelini S, MacDonald N, Smeds J, Jacobs IJ, Hemminki K, Das S, Akslen LA. Salvesen HB, et al. Int J Cancer. 2005 Jul 20;115(6):930-4. doi: 10.1002/ijc.20702. Int J Cancer. 2005. PMID: 15723290 Free article.

10

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.

Arnes JB, Brunet JS, Stefansson I, Bégin LR, Wong N, Chappuis PO, Akslen LA, Foulkes WD. Arnes JB, et al. Clin Cancer Res. 2005 Jun 1;11(11):4003-11. doi: 10.1158/1078-0432.CCR-04-2064. Clin Cancer Res. 2005. PMID: 15930334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page